Search

Your search keyword '"Joy D. Cogan"' showing total 79 results

Search Constraints

Start Over You searched for: Author "Joy D. Cogan" Remove constraint Author: "Joy D. Cogan" Topic humans Remove constraint Topic: humans
79 results on '"Joy D. Cogan"'

Search Results

1. Heterozygous loss-of-function variants significantly expand the phenotypes associated with loss of GDF11

2. A novel DPH5-related diphthamide-deficiency syndrome causing embryonic lethality or profound neurodevelopmental disorder

3. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain

4. The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis

5. Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases

6. Clinical sites of the Undiagnosed Diseases Network: unique contributions to genomic medicine and science

7. Lessons learned: next-generation sequencing applied to undiagnosed genetic diseases

8. Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder

9. De novo EIF2AK1 and EIF2AK2 Variants Are Associated with Developmental Delay, Leukoencephalopathy, and Neurologic Decompensation

10. Limitations of exome sequencing in detecting rare and undiagnosed diseases

11. Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy

12. Lysosomal Storage and Albinism Due to Effects of a De Novo CLCN7 Variant on Lysosomal Acidification

13. Expanding the Spectrum of BAF-Related Disorders: De Novo Variants in SMARCC2 Cause a Syndrome with Intellectual Disability and Developmental Delay

14. TBX4 Transcription Factor Is a Positive Feedback Regulator of Itself and Phospho-SMAD1/5

15. Identifying digenic disease genes via machine learning in the Undiagnosed Diseases Network

16. Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations

18. Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease

19. Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor beta Signaling

20. HACER: an atlas of human active enhancers to interpret regulatory variants

21. Phenotype risk scores identify patients with unrecognized Mendelian disease patterns

22. Phenotypic heterogeneity of ZMPSTE24 deficiency

23. Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia

24. Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids

25. Rare Genetic Variants in PARN Are Associated with Pulmonary Fibrosis in Families

26. Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis

27. The Undiagnosed Diseases Network: Accelerating Discovery about Health and Disease

28. A Recurrent De Novo Variant in NACC1 Causes a Syndrome Characterized by Infantile Epilepsy, Cataracts, and Profound Developmental Delay

29. A Syndromic Neurodevelopmental Disorder Caused by De Novo Variants in EBF3

30. The Y Chromosome Regulates BMPR2 Expression via SRY: A Possible Reason 'Why' Fewer Males Develop Pulmonary Arterial Hypertension

31. De Novo Pathogenic Variants in N-cadherin Cause a Syndromic Neurodevelopmental Disorder with Corpus Callosum, Axon, Cardiac, Ocular, and Genital Defects

32. De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia

33. Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

34. Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II–Associated Pulmonary Arterial Hypertension Through MicroRNA-29–Mediated Modulation of Cellular Metabolism

35. A Comprehensive Iterative Approach is Highly Effective in Diagnosing Individuals who are Exome Negative

36. Further evidence for the involvement of

37. Genome-Wide Association Study of 58 Individuals with Fibrosing Mediastinitis Reveals Possible Underlying Genetic Susceptibility

38. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases

39. MARRVEL: Integration of Human and Model Organism Genetic Resources to Facilitate Functional Annotation of the Human Genome

40. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype

41. Loss-of-function thrombospondin-1 mutations in familial pulmonary hypertension

42. Transcripts from a novelBMPR2termination mutation escape nonsense mediated decay by downstream translation re-initiation: implications for treating pulmonary hypertension

43. Short telomeres are a risk factor for idiopathic pulmonary fibrosis

44. Fibrosing mediastinitis complicating prior histoplasmosis is associated with human leukocyte antigen DQB1*04:02 − a case control study

45. Rare Variants in RTEL1 Are Associated with Familial Interstitial Pneumonia

46. Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension

47. Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease

48. Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension

49. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia

50. A Novel Mechanism of Aberrant Pre-mRNA Splicing in Humans

Catalog

Books, media, physical & digital resources